Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

US Patent 10973908 · Granted Apr 13, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric protein toxins for expression by therapeutic bacteria2025
Copper chelation therapeutics2024
Bacteria carrying bacteriophage and protease inhibitors for the treatment of dis2023
Modified bacteria having improved pharmacokinetics and tumor colonization enhanc2023
Modified bacteria having improved pharmacokinetics and tumor colonization enhanc2023
Protease inhibitor:protease sensitive expression system and method improving the2022
Copper chelation therapeutics2022
Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Sal2022
Protease inhibitor:protease sensitive expression system, composition and methods2022
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides2021
Chimeric protein toxins for expression by therapeutic bacteria2021
Immunization and/or treatment of parasites and infectious agents by live bacteri2021